Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteins
Open Access
- 9 May 2024
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 107, 129779
Abstract
No abstract availableKeywords
Funding Information
- HORIZON EUROPE European Research Council (851478)
- Horizon 2020
- Medizinische Universität Wien
- Austrian Science Fund (P36746, P31690, P7909, P32125, P5918723)
- Horizon 2020 Framework Programme
- Österreichische Akademie der Wissenschaften
- European Research Council
This publication has 21 references indexed in Scilit:
- Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive ChemistryJournal of the American Chemical Society, 2023
- Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1Journal of the American Chemical Society, 2022
- An E3 ligase guide to the galaxy of small-molecule-induced protein degradationCell Chemical Biology, 2021
- The role of reversible and irreversible covalent chemistry in targeted protein degradationCell Chemical Biology, 2021
- DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting ChimerasJournal of the American Chemical Society, 2021
- Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistryNature Communications, 2020
- Targeted protein degradation: current and future challengesCurrent Opinion in Chemical Biology, 2020
- Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACsJournal of the American Chemical Society, 2020
- BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 RecruitmentMolecular Cell, 2017
- Targeting biomolecules with reversible covalent chemistryCurrent Opinion in Chemical Biology, 2016